Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24 †
Titel:
Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24 †
Auteur:
Goodwin, R. Ding, K. Seymour, L. LeMaître, A. Arnold, A. Shepherd, F.A. Dediu, M. Ciuleanu, T. Fenton, D. Zukin, M. Walde, D. Laberge, F. Vincent, M. Ellis, P.M. Laurie, S.A.